About this document
Vaccine Adaptation to Virus Variants by api-548076336 is a document available to read on EtoBox.
Vaccine makers are assessing the effectiveness of vaccines against emerging virus variants, particularly B.1.351 from South Africa, which requires significantly higher antibody levels for efficacy. Studies show that Moderna and Pfizer vaccines are notably less effective against this variant and others like B.1.1.7 and P.1. In response, Moderna has initiated Phase I trials for booster shots targeting the B.1.351 mutation as research continues to adapt to these evolving threats.
- Author
- api-548076336
- Language
- EN